The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation
Open accessAbstract
Hepatocyte growth factor/scatter factor (HGF/SF), acting through the Met receptor, plays an important role in most human solid tumors, and inappropriate expression of this ligand–receptor pair is often associated with poor prognosis. The molecular basis for the malignant potential of the HGF/SF–Met signal in cancer cells has mostly been attributed to its mitogenic and invasive properties. However, HGF/SF also induces angiogenesis, but the signaling mechanism has not been fully explained, nor has this activity been directly associated with HGF/SF–Met-mediated tumorigenesis. It is known that HGF/SF induces in vitro expression of vascular endothelial growth factor (VEGF), a key agonist of tumor angiogenesis; by contrast, thrombospondin 1 (TSP-1) is a negative regulator of angiogenesis. Here, we show that, in the very same tumor cells, in addition to inducing VEGF expression, HGF/SF dramatically down-regulates TSP-1 expression. We show that TSP-1 shut-off plays an important, extrinsic role in HGF/SF-mediated tumor development, because ectopic expression of TSP-1 markedly inhibits tumor formation through the suppression of angiogenesis. Interestingly, although VEGF-induced expression is sensitive to inhibitors of several pathways, including mitogen-activated protein kinase, phosphoinositide 3-kinase, and signal transducer and activator of transcription 3, TSP-1 shut-off by HGF/SF is prevented solely by inhibiting mitogen-activated protein kinase activation. These studies identify HGF/SF as a key switch for turning on angiogenesis. They suggest that TSP-1 is a useful antagonist to tumor angiogenesis and that it may have therapeutic value when used in conjunction with inhibitors of VEGF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Watnick, R. S., Cheng, Y.-N., Rangarajan, A., Ince, T. A., & Weinberg, R. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00030-8 · Cited by 318
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Signal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
VEGF and the quest for tumour angiogenesis factors
Ferrara, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc909 · Cited by 1,536
Clinical translation of angiogenesis inhibitors
Kerbel, R., & Folkman, J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc905 · Cited by 1,517
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Self-citationBussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., & Comoglio, P. M. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.629 · Cited by 1,337
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205260 · Cited by 1,207
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
Jiménez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L., & Bouck, N. (2000) · Nature Medicine · doi:10.1038/71517 · Cited by 1,020
Self-citationProteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor
Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D., Ahn, N. G., Oskarsson, M. K., Fukasawa, K., Paull, K. D., et al. (1998) · Science · doi:10.1126/science.280.5364.734 · Cited by 1,008
Scatter-factor and semaphorin receptors: cell signalling for invasive growth
Trusolino, L., & Comoglio, P. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc779 · Cited by 745
Scatter factor induces blood vessel formation in vivo.
Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. L., Polverini, P., & Rosen, E. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1937 · Cited by 691
FERRARA, N. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70064-x · Cited by 623
Ferrara, N. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37264 · Cited by 546
c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression
Baudino, T. A., McKay, C., Pendeville-Samain, H., Nilsson, J. A., Maclean, K. H., White, E. L., Davis, A. C., Ihle, J. N., & Cleveland, J. L. (2002) · Genes & Development · doi:10.1101/gad.1024602 · Cited by 525
Rodríguez-Manzaneque, J. C., Lane, T. F., Ortega, M. A., Hynes, R. O., Lawler, J., & Iruela-Arispe, M. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171460498 · Cited by 473
Met receptor tyrosine kinase: enhanced signaling through adapter proteins
Furge, K. A., Zhang, Y.-W., & Vande Woude, G. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203859 · Cited by 410
Self-citationDong, G., Chen, Z., Li, Z. Y., Yeh, N. T., Bancroft, C. C., & Waes, C. V. (2001) · PubMed · Cited by 309
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1115 · Cited by 307
Rak, J. W., Mitsuhashi, Y., Sheehan, C., Tamir, A., Viloria‐Petit, A., Filmus, J., Mansour, S. J., Ahn, N. G., & Kerbel, R. S. (2000) · PubMed · Cited by 288
Tumor Suppressor p53 Protein Is a New Target for the Metastasis-associated Mts1/S100A4 Protein
Grigorian, M., Andresen, S., Tulchinsky, E., Kriajevska, M., Carlberg, C., Kruse, C., Cohn, M., Ambartsumian, N., Christensen, A., Selivanova, G., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010231200 · Cited by 282
Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis
Schwarte-Waldhoff, I., Volpert, O. V., Bouck, N. P., Sipos, B., Hahn, S. A., Klein-Scory, S., Lüttges, J., Klöppel, G., Graeven, U., Eilert-Micus, C., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9624 · Cited by 266
Self-citationPTEN controls tumor-induced angiogenesis
Wen, S., Stolarov, J., Myers, M. P., Su, J. D., Wigler, M. H., Tonks, N. K., & Durden, D. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081063798 · Cited by 241
Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M., & Nakamura, T. (2000) · PubMed · Cited by 227
Cao, B., Su, Y., Oskarsson, M., Zhao, P., Kort, E. J., Fisher, R. J., Wang, L.-M., & Vande Woude, G. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131200498 · Cited by 213
Self-citationRequirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis
Zhang, Y.-W., Wang, L.-M., Jove, R., & Vande Woude, G. F. (2002) · Oncogene · doi:10.1038/sj.onc.1205004 · Cited by 196
Self-citationMet–HGF/SF: Tumorigenesis, Invasion and Metastasis
Woude, G. F. V., Jeffers, M., Cortner, J., Alvord, G., Tsarfaty, I., & Resau, J. H. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515457.ch8 · Cited by 124
Self-citationBleuel, K., Popp, S., Fusenig, N. E., Stanbridge, E. J., & Boukamp, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2065 · Cited by 116
The Role of Thrombospondin-1 in Tumor Progression
Sargiannidou, I., Zhou, J., & Tuszynski, G. P. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020222600803 · Cited by 106
Duesbery, N. S., Resau, J. H., Webb, C. P., Koochekpour, S., Koo, H.-M., Leppla, S. H., & Woude, G. F. V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061031898 · Cited by 103
Self-citationAntiangiogenesis drug promising for metastatic colorectal cancer
McCarthy, M. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13603-3 · Cited by 94
Thomas‐Tikhonenko, A., Black, D. J., & Linial, M. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30741 · Cited by 90
Scatter Factor and Angiogenesis
Rosen, E. M., & Goldberg, I. D. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60715-0 · Cited by 86
Moriyama, T., Kataoka, H., Hamasuna, R., Yokogami, K., Uehara, H., Kawano, H., Goya, T., Tsubouchi, H., Koono, M., & Wakisaka, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9078 · Cited by 77
Dejong, V., Degeorges, A., Filleur, S., Ait‐Si‐Ali, S., Mettouchi, A., BORNSTEIN, P. K., Binétruy, B., & Cabon, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202654 · Cited by 67
Gutierrez, L. (2003) · Carcinogenesis · doi:10.1093/carcin/24.2.199 · Cited by 60
Expression and role of thrombospondin-1 in colorectal cancer.
Miyanaga, K., Kato, Y. P., Nakamura, T., Matsumura, M., Amaya, H., Horiuchi, T., Chiba, Y., & Tanaka, K. (2002) · PubMed · Cited by 50
Guo, N., Zabrenetzky, V. S., Chandrasekaran, L., Sipes, J. M., Lawler, J., Krutzsch, H. C., & Roberts, D. D. (1998) · PubMed · Cited by 49
Modulating apoptosis pathways in low-grade B-cell malignancies using biological response modifiers
Reed, J. C., Kitada, S., Kim, Y., & Byrd, J. C. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.30155 · Cited by 47
Cited by
Targeting MET in cancer: rationale and progress
Gherardi, E., Birchmeier, W., Birchmeier, C., & Woude, G. V. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3205 · Cited by 1,423
Self-citationZou, H. Y., Li, Q., Lee, J. H., Arango, M. E., McDonnell, S. R., Yamazaki, S., Koudriakova, T. B., Alton, G., Cui, J. J., Kung, P.-P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4443 · Cited by 745
Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
Eder, J. P., Vande Woude, G. F., Boerner, S. A., & LoRusso, P. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1306 · Cited by 522
c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention
Christensen, J. G., Burrows, J., & Salgia, R. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.09.044 · Cited by 513
Kopetz, S., Hoff, P. M., Morris, J. S., Wolff, R. A., Eng, C., Glover, K. Y., Adinin, R., Overman, M. J., Valero, V., Wen, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.8252 · Cited by 485
Metadata
- Authors
- Zhang, Y.-W., Su, Y., Volpert, O. V., & Woude, G. F. V.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-10-10
- Volume
- 100
- Issue
- 22
- Pages
- 12718-12723
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2045115099
- Cited by
- 348
- References
- 40
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.